Longevity MitoRx secures $7.2m to advance obesity treatmentBy adminNovember 26, 20250 MitoRx raises new funding to advance Myo-004, a first-in-class mitochondrial-targeted obesity treatment that aims to preserve lean mass. Oxford-based biotechnology…
